Table 3.
Parametera | Control group | Contaminated group (a) | Treated contaminated group (b) | p value a vs. b |
---|---|---|---|---|
Study 1 | ||||
Sa/So ratio (42 days) | 0.15 | 0.28 | 0.16 | 0.005 |
Study 2 | ||||
Sa/So ratio (28 days) | – | 0.27 | 0.19 | 0.038 |
Sa/So ratio (42 days) | – | 0.27 | 0.22 | 0.076 |
FB1 (42 days) | – | 5.76 | 0.37 | 0.010 |
pHFB1a (42 days) | – | 1.01 | 0.40 | 0.210 |
pHFB1b (42 days) | – | 0.69 | 0.47 | 0.487 |
HFB1 (42 days) | – | 0.11 | 2.60 | 0.029 |
Study 3 | ||||
Sa/So ratio (14 days) | 0.14 | 0.16 | 0.13 | 0.045 |
Sa/So ratio (28 days) | 0.14 | 0.25 | 0.14 | 0.003 |
Sa/So ratio (41 days) | 0.13 | 0.21 | 0.14 | 0.021 |
Sa/So: sphinganine/sphingosine ratio; pHFB1a, pHFB1b: partially hydrolysed fumonisin; HFB1: fully de‐esterified fumonisin.